These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 26118953)
1. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha protects cardiomyocytes from hypertrophy by suppressing calcineurin-nuclear factor of activated T cells c4 signaling pathway. Liu XP; Gao H; Huang XY; Chen YF; Feng XJ; He YH; Li ZM; Liu PQ Transl Res; 2015 Nov; 166(5):459-473.e3. PubMed ID: 26118953 [TBL] [Abstract][Full Text] [Related]
2. Mitochondrial Disruption Is Involved in the Effect of Nuclear Factor of Activated T cells, Cytoplasmic 4 on Aggravating Cardiomyocyte Hypertrophy. Liu X; Gao S; Gao H; Jiang X; Wei Q J Cardiovasc Pharmacol; 2021 May; 77(5):557-569. PubMed ID: 33951694 [TBL] [Abstract][Full Text] [Related]
3. The protective role of peroxisome proliferator-activated receptor γ coactivator-1α in hyperthyroid cardiac hypertrophy. Xu W; Hou D; Jiang X; Lu Z; Guo T; Liu Y; Wang D; Zen K; Yu B; Zhang CY J Cell Physiol; 2012 Sep; 227(9):3243-53. PubMed ID: 22105890 [TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis. Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576 [TBL] [Abstract][Full Text] [Related]
5. [Effects of hydrogen sulfide (H Wu Y; Guo YY; Zhang YY; Zhang Y Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan; 34(1):29-34. PubMed ID: 29926655 [TBL] [Abstract][Full Text] [Related]
6. NFATc4 and myocardin synergistically up-regulate the expression of LTCC α1C in ET-1-induced cardiomyocyte hypertrophy. Li M; He HP; Gong HQ; Zhang J; Ma WJ; Zhou H; Cao DS; Wang N; Zhang TC Life Sci; 2016 Jun; 155():11-20. PubMed ID: 27155398 [TBL] [Abstract][Full Text] [Related]
7. Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-α partly via preventing p65-NFκB binding to NFATc4. Zou J; Le K; Xu S; Chen J; Liu Z; Chao X; Geng B; Luo J; Zeng S; Ye J; Liu P Mol Cell Endocrinol; 2013 May; 370(1-2):103-12. PubMed ID: 23518069 [TBL] [Abstract][Full Text] [Related]
8. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling. Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855 [TBL] [Abstract][Full Text] [Related]
9. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3. Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639 [TBL] [Abstract][Full Text] [Related]
11. PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4. Le K; Li R; Xu S; Wu X; Huang H; Bao Y; Cai Y; Lan T; Moss J; Li C; Zou J; Shen X; Liu P Arch Biochem Biophys; 2012 Feb; 518(1):71-8. PubMed ID: 22198280 [TBL] [Abstract][Full Text] [Related]
12. Curcumin regulates peroxisome proliferator-activated receptor-γ coactivator-1α expression by AMPK pathway in hepatic stellate cells in vitro. Zhai X; Qiao H; Guan W; Li Z; Cheng Y; Jia X; Zhou Y Eur J Pharmacol; 2015 Jan; 746():56-62. PubMed ID: 25445048 [TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy. Cai B; Tan X; Zhang Y; Li X; Wang X; Zhu J; Wang Y; Yang F; Wang B; Liu Y; Xu C; Pan Z; Wang N; Yang B; Lu Y Stem Cells Transl Med; 2015 Dec; 4(12):1425-35. PubMed ID: 26586774 [TBL] [Abstract][Full Text] [Related]
14. Roles of transcriptional corepressor RIP140 and coactivator PGC-1α in energy state of chronically infarcted rat hearts and mitochondrial function of cardiomyocytes. Chen Y; Wang Y; Chen J; Chen X; Cao W; Chen S; Xu S; Huang H; Liu P Mol Cell Endocrinol; 2012 Oct; 362(1-2):11-8. PubMed ID: 22503866 [TBL] [Abstract][Full Text] [Related]
15. Activation of peroxisome proliferator-activated receptor-alpha prevents glycogen synthase 3beta phosphorylation and inhibits cardiac hypertrophy. Li R; Zheng W; Pi R; Gao J; Zhang H; Wang P; Le K; Liu P FEBS Lett; 2007 Jul; 581(17):3311-6. PubMed ID: 17597616 [TBL] [Abstract][Full Text] [Related]
16. Novel PGC-1 Zhang B; Tan Y; Zhang Z; Feng P; Ding W; Wang Q; Liang H; Duan W; Wang X; Yu S; Liu J; Yi D; Sun Y; Yi W Oxid Med Cell Longev; 2020; 2020():9187065. PubMed ID: 33425220 [TBL] [Abstract][Full Text] [Related]
18. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy. Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876 [TBL] [Abstract][Full Text] [Related]
19. Canstatin suppresses isoproterenol-induced cardiac hypertrophy through inhibition of calcineurin/nuclear factor of activated T-cells pathway in rats. Sugiyama A; Okada M; Yamawaki H Eur J Pharmacol; 2020 Mar; 871():172849. PubMed ID: 31843516 [TBL] [Abstract][Full Text] [Related]
20. Astragalus polysaccharide attenuates isoproterenol-induced cardiac hypertrophy by regulating TNF-α/PGC-1α signaling mediated energy biosynthesis. Luan A; Tang F; Yang Y; Lu M; Wang H; Zhang Y Environ Toxicol Pharmacol; 2015 May; 39(3):1081-90. PubMed ID: 25880160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]